Recall of LEGIONELLA GROWTH SUPPLEMENT

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by OXOID COMPANY.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    39228
  • Event Risk Class
    III
  • Event Initiated Date
    2015-02-18
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    A technical investigation has found that specific lots of oxoid legionella bcye growth supplement (sr0110a) may not deliver adequate recovery of legionella pneumophila when used in conjunction with oxoid legionella medium (cm0655) and also with oxoid legionella selective supplement variants. continued use of these lots could result in false negative reporting.

Device

  • Model / Serial
    Model Catalog: SR0110A (Lot serial: 1545171); Model Catalog: SR0110A (Lot serial: 1545172)
  • Product Description
    OXOID LEGIONELLA BCYE GROWTH SUPPLEMENT
  • Manufacturer

Manufacturer